UPDATE 1-France's Ipsen to buy some Merrimack assets for up to $1 bln
January 08, 2017 at 21:37 PM EST
Jan 9 (Reuters) - French drugmaker Ipsen SA said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc, including its pancreatic cancer treatment Onivyde, for up to $1 billion.
